Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.

@article{Ozturk2011ComparisonOI,
  title={Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.},
  author={Banu Turgut Ozturk and Hurkan Kerimoglu and B. Ş{\"u}kr{\"u} Bozkurt and Suleyman Okudan},
  journal={Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics},
  year={2011},
  volume={27 4},
  pages={373-7}
}
AIM The aim of this study was to compare the effects of bevacizumab and ranibizumab on visual function and macular thickness in patients with diabetic macular edema (DME). METHODS The data of diabetic patients who had been treated with bevacizumab for DME were reviewed. Those patients who received 1 injection of intravitreal bevacizumab and ranibizumab with at least 6-month interval were considered for enrollment. The best-corrected visual acuity (BCVA) assesment with Early Treatment Diabetic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…